| Literature DB >> 30364457 |
Ghous Bux Somroo1, Ayesha Aslam Rai1, Nasir Hassan Luck1, Zaigham Abbas1.
Abstract
INTRODUCTION: Autoimmune hepatitis (AIH) is one of the most common disorder resulting in end stage liver disease (ESLD) among children. Scarce data is available in this regard from Pakistan. In this study we have analyzed clinical and biochemical parameters of children suffering from this disorder.Entities:
Keywords: Autoimmune hepatitis; end stage liver disease liver disease; hypergammaglobulinemia
Mesh:
Year: 2018 PMID: 30364457 PMCID: PMC6196082 DOI: 10.11604/pamj.2018.30.117.12692
Source DB: PubMed Journal: Pan Afr Med J
Basic demographic data, clinical and laboratory parameter of study population
| Variables | Number (Percentage) |
|---|---|
| Gender | |
| Male | 16 (31.4%) |
| Female | 35 (68.6%) |
| Clinical Cirrhosis | |
| Present | 35 (68.6%) |
| Absent | 16 (31.4%) |
| History and General Physical Examination | |
| Hepatomegaly | 6 (11.8%) |
| Splenomegaly | 13 (25.5%) |
| Hepatosplenomegaly | 25 (49%) |
| No visceromegaly | 7 (13.7%) |
| Jaundice | 44 (86.3%) |
| Abdominal pain | 25 (49%) |
| Abdominal distension | 32 (62.7%) |
| Edema | 7 (13.7%) |
| Malaise | 29 (56.9%) |
| Fever | 16 (31.4%) |
| HLA Typing | |
| HLA DR3 and DR4 | 1 (2%) |
| HLA DR3 | 9 (17.6%) |
| Other HLA | 5 (9.8%) |
| Not done | 36 (70.6%) |
| Types of AIH | |
| Type I | 34 (66.7%) |
| Type II | 5 (9.8%) |
| Seronegative AIH | 12 (23.5%) |
Clinical and biochemical parameters of study population (n=51)
| Variables | Range | Mean±SD | Median |
|---|---|---|---|
| Age in years | 4-17 | 10.16± 3.3 | 10 |
| IAIHG score | 10-21 | 13.88±2.73 | 14 |
| AIH score | 6-8 | 6.8±0.74 | 7 |
| Hb (g/L) | 5-13.7 | 9.63±1.82 | 9.7 |
| Platelets (x 103/µL) | 22-375 | 140.53±80.48 | 126 |
| TLC (x 103/µL) | 1.2-15.1 | 6.7±1.33 | 6.5 |
| Urea (mg/dL) | 4-51 | 19.06±9.97 | 17 |
| Creatinine (mg/dL) | 0.1-1.76 | 0.45±0.30 | 0.4 |
| Albumin (g/dL) | 1.3-4.4 | 2.8±0.73 | 2.9 |
| T. Bilirubin (mg/dL) | 0.12-49.41 | 4.13±7.67 | 1.7 |
| D. Bilirubin (mg/dL) | 0.012-25.78 | 2.07±4.23 | 0.59 |
| Alkaline Phosphatase (U/L) | 42-1039 | 345.60±229.12 | 287 |
| ALT (U/L) | 17-1510 | 136.14±220.53 | 78 |
| AST (U/L) | 24-844 | 149.2±171.43 | 78 |
| GGT (U/L) | 12-486 | 89.55±82.91 | 70 |
| PT (in seconds) | 10.7-36 | 15.37±4.98 | 14.1 |
| INR | 0.93-3.10 | 1.41±0.41 | 1.34 |
| IgG (g/dL) | 12.6-55.63 | 25.22±8.82 | 22.6 |
| IgM (g/dL) | 0.87-27.2 | 3.06±4.63 | 2.21 |
| IgA (g/dL) | 1.5-7.88 | 3.32±1.79 | 2.89 |
| C3 | 0.3-3.53 | 0.97±0.67 | 0.98 |
| C4 | 0.03-0.89 | 0.22±0.21 | 0.20 |
Patient’s clinical, biochemical and histological parameters at time of diagnosis according to the gender distribution (n=51)
| Parameters | Female ( n=35) | Male (n =16) | p-value |
|---|---|---|---|
| Age (mean ±SD) | 12.1±3.4 | 9.5±2.8 | 0.007 |
| Clinical Cirrhosis | 24 | 11 | 1.00 |
| ALT (mean ±SD) IU/L | 137±251.6 | 134.1±136.4 | 0.966 |
| D. Bilirubin (mean ±SD) mg/dL | 2.1 ± 4.9 | 1.9±1.9 | 0.918 |
| GGT(mean ±SD) IU/L | 72.8±54.8 | 126±118.4 | 0.032 |
| Albumin (mean ±SD) g/dL | 2.8±0.7 | 2.6±0.6 | 0.19 |
| INR (mean ±SD) | 1.39±0.4 | 1.45±0.3 | 0.668 |
| IgG (mean ±SD) | 25.4±9.6 | 24.6±7.0 | 0.769 |
| Plasma cell infiltrate | 23 | 11 | 0.726 |
| Rosette formation | 10 | 6 | 1.000 |
| Piecemeal necrosis | 24 | 9 | 0.167 |
| IAIHG | 14.0±2.7 | 13.5±2.6 | 0.505 |
|
| |||
| Type I | 27 | 7 | 0.019 |
| Type II | 1 | 4 | |
| Seronegative | 7 | 5 |
Patient’s clinical, biochemical and histological parameters at time of diagnosis according to the types of AIH (n=51)
| Parameters | Type I | Type II | Seronegative | p-value |
|---|---|---|---|---|
| Age (mean ±SD) | 10.1±3.1 | 12.2±2.7 | 10±3.7 | 0.409 |
| Gender (Male/Female) | 7/27 | 4/1 | 5/7 | 0.019 |
| Clinical Cirrhosis | 21 | 4 | 10 | 0.325 |
| ALT (mean ±SD) IU/L | 133.1±255.2 | 80.4±45.0 | 167.8±149.5 | 0.758 |
| D. Bilirubin (mean ±SD) mg/dL | 1.9±4.6 | 1.4±1.2 | 2.8±4.0 | 0.762 |
| GGT(mean ±SD) IU/L | 69.1±50.7 | 205.6±159.5 | 99±82.7 | 0.001 |
| Albumin (mean ±SD) g/dL | 2.8±0.6 | 2.9±0.8 | 2.5±0.8 | 0.413 |
| INR (mean ±SD) | 1.3 ± 0.3 | 1.3±0.2 | 1.5±0.5 | 0.102 |
| IgG (mean ±SD) | 24.4±7.0 | 29.9±12.1 | 25.4±11.8 | 0.432 |
| Plasma cell infiltrate | 23 | 3 | 8 | 0.531 |
| Rosette formation | 14 | 0 | 2 | 0.035 |
| Piecemeal necrosis | 21 | 3 | 9 | 0.815 |